Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma Biogen posted strong Q4 results, surpassing estimates, while forecasting a 2025 ...
Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) missed Wall Street’s revenue expectations in Q4 CY2024, with sales ...
Royalty Management Holding Corp. engages in investing or purchasing assets that have current or near-term income. The company was founded on June 21, 2021 and is headquartered in Fishers, IN. U.S ...
2 Uranium Stocks Fueling Growth From the Nuclear Power Surge Uranium stocks have been surging thanks to the Constellation Energy Co. (NASDAQ: CEG) and Microsoft Co. deal for the largest power ...
2022 BP Prudhoe Bay Royalty Trust 3.78 32.34 USD 2021 BP Prudhoe Bay Royalty Trust 0.09 2.39 USD 2020 BP Prudhoe Bay Royalty Trust 0.42 17.83 USD 2019 BP Prudhoe Bay Royalty Trust 2.23 32.47 USD ...
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback